!

COVID-19 Response

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Research

Center for Skeletal Medicine and Biology

Master
Heading

About Us

Content

The Center for Skeletal Medicine and Biology brings together diverse researchers at Baylor College of Medicine to develop coordinated clinical and basic science research and provide training opportunities more broadly focused on musculoskeletal health. The center is part of the Rolanette and Berdon Lawrence Bone Disease Program of Texas, a collaborative research, clinical and education program of Baylor College of Medicine, The University of Texas MD Anderson Cancer Center and The University of Texas Health Sciences Center.

The Rolanette and Berdon Lawrence Bone Disease Program of Texas provides services to assist investigators in the bone disease program working with skeletal tissues. See information for each service available:

Heading

Center Faculty

Content

Research participants from Baylor College of Medicine and partner institutions work to translate basic science discoveries to more effective treatment and prevention options. See list of Baylor participants and information on each.

Heading

Cores

Content

Cores provide technical and training services to assist investigators at Baylor College of Medicine and in the Bone Disease Program.

Heading

Seminars/Grand Rounds

Content

A range of seminars and training opportunities are available for individuals interested in musculoskeletal health.

Heading

What to expect within the tumor microenvironment

Content

Dr. Xiang Zhang conducted a series of analyses to profile the immune cell composition of tumor microenvironments in eight murine models and in clinical datasets of triple-negative breast cancers.

Heading

No SOX9, no cartilage; and how DDRGK1 causes a rare human skeletal dysplasia

Content

Dr. Brendan Lee, professor and chair of molecular and human genetics at Baylor, and a team of researchers including project leader Adetutu Egunsola, a genetics graduate student in the Lee lab, set out to identify the genetic driver behind SEMD.

Heading

Research shows bone-building protein can be used in therapy

Content

The WNT1 ligand has previously been identified in bone disease, but its role in bone homeostasis, its cellular source and targets in bone have only just recently been identified.

Back to topback-to-top